LeMaitre Vascular (LMAT) insider details option exercises and trust transfer
Rhea-AI Filing Summary
LeMaitre Vascular Inc. reported insider activity by its chairman and CEO, who is also a director, involving multiple transactions in company common stock on 12/11/2025 and 12/12/2025. The activity included exercises of stock options at exercise prices of $37.29, $48.6, $47.19 and $54.65, as well as releases of dividend equivalent rights that resulted in share acquisitions at $0 per share.
The filing notes that several dispositions reflect shares withheld by the issuer to cover tax obligations tied to vesting restricted stock units and performance stock units, treated as exempt sales under Rule 16b-3(e). It also records a transfer of 12,100 shares from the reporting person’s direct holdings to the LeMaitre Irrevocable Life Insurance Trust of 2025. After these transactions, the reporting person directly owns 1,682,304 common shares, and 33,400 shares are held indirectly by the trust.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 5,155 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 7,733 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 7,075 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 6,182 | $0.00 | -- |
| Exercise | Dividend Equivalent Rights | 39 | $0.00 | -- |
| Exercise | Dividend Equivalent Rights | 39 | $0.00 | -- |
| Exercise | Common Stock | 5,155 | $37.29 | $192K |
| Exercise | Common Stock | 7,733 | $48.60 | $376K |
| Exercise | Common Stock | 7,075 | $47.19 | $334K |
| Exercise | Common Stock | 6,182 | $54.65 | $338K |
| Gift | Common Stock | 12,100 | $0.00 | -- |
| Grant/Award | Common Stock | 12,100 | $0.00 | -- |
| Exercise | Common Stock | 39 | $0.00 | -- |
| Tax Withholding | Common Stock | 663 | $84.00 | $56K |
| Exercise | Common Stock | 39 | $0.00 | -- |
| Tax Withholding | Common Stock | 663 | $84.00 | $56K |
| Exercise | Dividend Equivalent Rights | 54 | $0.00 | -- |
| Exercise | Common Stock | 54 | $0.00 | -- |
| Tax Withholding | Common Stock | 652 | $83.36 | $54K |
Footnotes (1)
- Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/11/2021. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose. These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Fractional shares released (if any) on each vesting date were settled in cash, resulting in a final balance of zero. This option is fully vested and exercisable. This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
FAQ
What insider transactions did LeMaitre Vascular (LMAT) report in this filing?
The filing shows the chairman and CEO executed multiple transactions in LeMaitre Vascular common stock on 12/11/2025 and 12/12/2025, including stock option exercises, releases of dividend equivalent rights, share transfers, and share withholding for taxes on equity awards.
What stock options did the LeMaitre Vascular insider exercise in this Form 4?
The insider exercised stock options covering shares of LeMaitre Vascular common stock at exercise prices of $37.29, $48.6, $47.19, and $54.65, as reflected in the non-derivative and derivative tables.
What is the LeMaitre Irrevocable Life Insurance Trust of 2025 mentioned in the filing?
The filing reports that 12,100 shares of LeMaitre Vascular common stock were transferred from the reporting person’s direct holdings to the LeMaitre Irrevocable Life Insurance Trust of 2025, which holds shares for the benefit of the reporting person’s child or children.
How are dividend equivalent rights treated in this LeMaitre Vascular Form 4?
The filing explains that certain dividend equivalent rights were released in connection with vesting restricted stock unit and performance stock unit awards, with each right being the economic equivalent of one share of LeMaitre Vascular common stock.